Therapeutic Potential of Resveratrol and Atorvastatin Following High-Fat Diet Uptake-Induced Nonalcoholic Fatty Liver Disease by Targeting Genes Involved in Cholesterol Metabolism and miR33-Reference-Cited by-同舟云学术

Therapeutic Potential of Resveratrol and Atorvastatin Following High-Fat Diet Uptake-Induced Nonalcoholic Fatty Liver Disease by Targeting Genes Involved in Cholesterol Metabolism and miR33

Published:2023-02-01 Issue:2 Volume:42 Page:82-90
ISSN:1044-5498
Container-title:DNA and Cell Biology
language:en
Short-container-title:DNA and Cell Biology

Author:

Yarahmadi Sahar¹^ORCID,Farahmandian Navid¹,Fadaei Reza²,Koushki Mehdi³,Bahreini Elham¹^ORCID,Karima Saeed⁴,Barzin Tond Sepideh⁴^ORCID,Rezaei Azadeh¹,Nourbakhsh Mitra¹,Fallah Soudabeh¹

Affiliation:

1. Department of Biochemistry, School of Medicine Iran University of Medical Sciences, Tehran, Iran.

2. Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

3. Department of Clinical Biochemistry, School of Medicine Zanjan University of Medical Sciences, Zanjan, Iran.

4. Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Genetics,Molecular Biology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/dna.2022.0581

Reference8 articles.

1. Modulators of Protein Kinase C Affect SR-BI-Dependent HDL Lipid Uptake in Transfected HepG2 Cells

2. The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients

3. Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease

4. CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice

5. Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions;Pharmaceuticals;2024-08-15

2. Current strategies for nonalcoholic fatty liver disease treatment (Review);International Journal of Molecular Medicine;2024-08-08

3. Resveratrol suppresses hepatic fatty acid synthesis and increases fatty acid β-oxidation via the microRNA-33/SIRT6 signaling pathway;Experimental and Therapeutic Medicine;2024-06-19

4. Acacetin Decreases Atherosclerosis by Inhibiting Macrophage Lipid Accumulation via the miR-199a-5p/ABCA1 Signaling Pathway;2024

5. Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation;International Journal of Molecular Sciences;2023-04-25